Skip to main content
Fig. 2 | Allergy, Asthma & Clinical Immunology

Fig. 2

From: Stability of peripheral blood immune markers in patients with asthma

Fig. 2

Boxplots of physiological [a FEV1 (% predicted) and FEV1/FVC) and b ACQ score (ACQ7 and ACQ5)] and blood immune parameters [c % of Eosinophils in PB (Kimura), d % of Eosinophils in PB (Flow), e % of ILC2 in PB, f % of CD4+CRTh2+T cells in PB, g % of CD4+T cells expressing CRTh2, h % of CD14++CD16+ monocytes in PB, i % of CD14++D16 monocytes in PB, j % of CD14++CD16+PAR-2+ cells in PB, k % of CD14++CD16+ cells expressing PAR-2, l % of DC in PB (myeloid and plasmacytoid), m % of DC expressing FcεR1(myeloid and plasmacytoid)] for the whole population during the first visit (recruitment visit)

Back to article page